The effects of 13 wk of liraglutide treatment on endocrine and exocrine pancreas in male and female ZDF rats: a quantitative and qualitative analysis revealing no evidence of drug-induced pancreatitis
| Autor: | Inger Thorup, Andres Eskjær Jensen, Niels Vrang, Henrik Søeborg, Lotte Simonsen, Lotte Bjerre Knudsen, Jacob Jelsing |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
Blood Glucose
Male medicine.medical_specialty Physiology Endocrinology Diabetes and Metabolism Stereology Pancreatic alpha-Amylases Glucagon-Like Peptide 1 Physiology (medical) Internal medicine Diabetes mellitus medicine Animals Hypoglycemic Agents Endocrine system Pancreas Cell Proliferation Glycated Hemoglobin Venoms Liraglutide Drug induced pancreatitis business.industry Lipase medicine.disease Zdf rats Rats Rats Zucker Endocrinology Pancreatitis Exenatide Female Peptides business medicine.drug |
| Zdroj: | American Journal of Physiology-Endocrinology and Metabolism. 303:E253-E264 |
| ISSN: | 1522-1555 0193-1849 |
| Popis: | A possible association between glucagon-like peptide-1 (GLP-1) analogs and incidences of pancreatitis has been suggested based on clinical studies. In male and female diabetic Zucker diabetic fatty (ZDF) rats, we investigated the effects of continuous administration of liraglutide and exenatide on biochemical [lipase, pancreatic amylase (P-amylase)] and histopathological markers of pancreatitis. Male and female ZDF rats were dosed for 13 wk with liraglutide (0.4 or 1.0 mg·kg−1·day−1sc once daily) or exenatide (0.25 mg·kg−1·day−1sc, Alzet osmotic minipumps). P-amylase and lipase plasma activity were measured, and an extended histopathological and stereological (specific cell mass and proliferation rate) evaluation of the exocrine and the endocrine pancreas was performed. Expectedly, liraglutide and exenatide lowered blood glucose and Hb A1cin male and female ZDF rats, whereas β-cell mass and proliferation rate were increased with greatly improved blood glucose control. Whereas neither analog affected lipase activity, small increases in P-amylase activity were observed in animals treated with liraglutide and exenatide. However, concurrent or permanent increases in lipase and P-amylase activity were never observed. Triglycerides were lowered by both GLP-1 analogs. The qualitative histopathological findings did not reveal adverse effects of liraglutide. The findings were mainly minimal in severity and focal in distribution. Similarly, the quantitative stereological analyses revealed no effects of liraglutide or exenatide on overall pancreas weight or exocrine and duct cell mass or proliferation. The present study demonstrates that, in overtly diabetic male and female ZDF rats, prolonged exposure to GLP-1 receptor agonists does not affect biochemical or histopathological markers of pancreatitis, and whereas both exenatide and liraglutide increase β-cell mass, they have no effect on the exocrine pancreas. However, clinical outcome studies and studies using primate tissues and/or studies in nonhuman primates are needed to further assess human risk. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|